503A compounding vs commercial manufacturing: what is different
A quick, plain-language guide to what changes — and what does not — when a medication is compounded for one patient instead of mass-produced.
TL;DR
A 503A pharmacy (a section of federal law covering patient-specific compounding) makes one prescription at a time for a named patient. It follows USP <795>/<797> quality standards. Commercial manufacturers mass-produce a fixed, FDA-approved formula under cGMP (current Good Manufacturing Practice). Compounded products are never FDA-approved as finished items, even when the active ingredient is.
What is a 503A compounding pharmacy
A 503A compounding pharmacy prepares medication only after a licensed prescriber orders it for one specific patient. It is not making shelf stock. It operates under state board of pharmacy licensing and USP <795>/<797> standards, not the FDA's new-drug approval pathway.
How 503A vs commercial manufacturing works
Think of a tailor cutting one suit to your measurements, versus a factory sewing thousands of the same size. A 503A pharmacist adjusts dose, strength, or delivery form for that one prescription. A commercial manufacturer instead runs one fixed formula through cGMP-controlled batches. Each batch is tested before release, under 21 CFR Parts 210 and 211.
Who asks about it
Patients and prescribers ask this when a commercial dose does not fit. Maybe the strength is not commercially available. Maybe the ingredient combination is one no manufacturer sells. Maybe a patient cannot tolerate a filler in the commercial version. Telehealth patients researching peptide therapy often ask this question first, before they ask about any specific ingredient.
What the research says
Congress passed the Drug Quality and Security Act (DQSA) in 2013, after the 2012 fungal meningitis outbreak. It created Section 503B as an added oversight tier (fda.gov, 2023 guidance). Under FDA guidance, 503A pharmacies follow USP <795> and <797>. They are not required to meet cGMP, the standard applied to commercial manufacturers and 503B outsourcing facilities (fda.gov, 2023).
What to know before considering it
A compounded medication is not FDA-approved as a finished product, even if it contains an FDA-approved active ingredient. The compounded version itself did not go through FDA review. Ask any pharmacy about its USP compliance and state licensing before use. Also ask whether it is 503A (patient-specific) or 503B (batch production under cGMP). The two carry different oversight and different sterility testing requirements.
The Halftime POV
We route compounding through pharmacies that document USP <795>/<797> compliance and state licensing, and we're transparent that compounded products are not FDA-approved.
Related reading:
- /learning-center/503a-what-it-is
- /learning-center/503a-vs-503b-explained
- /learning-center/sterility-testing-compounded-peptides
- /learning-center/how-to-choose-a-quality-peptide-compounding-pharmacy-the-quality-signals
FAQ
What is a 503A compounding pharmacy? A 503A compounding pharmacy (named for a section of federal law) prepares one medication at a time. A licensed prescriber must order it for one named patient. It follows USP <795> and USP <797> standards and state board of pharmacy oversight, not the FDA drug-approval process.
How is compounding different from commercial drug manufacturing? Commercial manufacturers mass-produce a fixed-formula drug that the FDA reviewed and approved before sale. A 503A pharmacy makes one prescription at a time. It can adjust dose or form for that patient, and it is not subject to cGMP batch-release testing.
Is 503A compounding FDA approved? No. Compounded medications from a 503A pharmacy are not FDA-approved as finished products. The FDA does not review or approve each compounded preparation. Oversight instead runs through USP quality standards and the state board of pharmacy.
Does a 503A pharmacy have to follow cGMP? No. cGMP is the batch-manufacturing quality system required of commercial drug makers and 503B outsourcing facilities. 503A pharmacies instead follow USP <795> (nonsterile) and USP <797> (sterile) compounding standards.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Want to know when Halftime Health launches, and how we vet our compounding partners? Join the waitlist for updates.
Sources
- U.S. Food and Drug Administration. "Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act" (Guidance). fda.gov, 2023. https://www.fda.gov/files/drugs/published/Pharmacy-Compounding-of-Human-Drug-Products-Under-Section-503A-of-the-Federal-Food--Drug--and-Cosmetic-Act-Guidance.pdf
- U.S. Food and Drug Administration. "FDA's Compounding Program" (Dominic Markwordt, JD, Regulatory Counsel). fda.gov, 2023. https://www.fda.gov/media/156360/download
Frequently asked questions
what is a 503A compounding pharmacy
A 503A compounding pharmacy (named for a section of federal law) prepares one medication at a time. A licensed prescriber must order it for one named patient. It follows USP <795> and USP <797> standards and state board of pharmacy oversight, not the FDA drug-approval process.
how is compounding different from commercial drug manufacturing
Commercial manufacturers mass-produce a fixed-formula drug that the FDA reviewed and approved before sale. A 503A pharmacy makes one prescription at a time. It can adjust dose or form for that patient, and it is not subject to cGMP (current Good Manufacturing Practice) batch-release testing.
is 503A compounding FDA approved
No. Compounded medications from a 503A pharmacy are not FDA-approved as finished products. The FDA does not review or approve each compounded preparation. Oversight instead runs through USP quality standards and the state board of pharmacy.
does a 503A pharmacy have to follow cGMP
No. cGMP (current Good Manufacturing Practice) is the batch-manufacturing quality system required of commercial drug makers and 503B outsourcing facilities. 503A pharmacies instead follow USP <795> (nonsterile) and USP <797> (sterile) compounding standards.
